Evidence map›Paper›PMID 39592486›Full record

ArticleEuropean radiology2025

3-Tesla amide proton transfer-weighted imaging (APT-WI): elevated signal also in tumor mimics.

Guillaume Hamon, Augustin Lecler, Jean-Christophe Ferré, Pierre Bourdillon, Loïc Duron, Julien Savatovsky

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guillaume HamonDepartment of Neuroradiology, University Hospital Pontchaillou, Rennes, France.
Augustin LeclerDepartment of Neuroradiology, Rothschild Foundation Hospital, Paris, France. alecler@for.paris.ORCID http://orcid.org/0000-0001-7869-1815
Jean-Christophe FerréDepartment of Neuroradiology, University Hospital Pontchaillou, Rennes, France.
Pierre BourdillonDepartment of Neurosurgery, Rothschild Foundation Hospital, Paris, France.
Loïc DuronDepartment of Neuroradiology, Rothschild Foundation Hospital, Paris, France.
Julien SavatovskyDepartment of Neuroradiology, Rothschild Foundation Hospital, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore amide proton transfer-weighted imaging (APTwi) for the initial classification of brain masses in clinical practice by systematically reporting APTwi signal intensity (APT-SI) in tumor mimics and brain tumors. MATERIALS AND

methodsSingle-center retrospective analysis (2017-2020) of APTwi in 156 patients (84 men, mean age: 50.9 ± 20) who underwent characterization imaging of a brain mass prior to any treatment, using 3-Tesla MRI. 125/156 (80%) patients presented with brain tumor and 31/156 (20%) with tumor mimics. Regions of interest were manually drawn on 2D axial slices by two readers on APTwi map in lesional and perilesional areas and APT-SI, corresponding to the Magnetization Transfer Ratio asymmetry at 3.5 ppm, was systematically reported. Student's t-test or Wilcoxon-test were used to compare groups of patients.

resultsThe mean APT-SI in lesional and perilesional areas were significantly higher in tumors compared to tumor mimics: 3% [2.10-4] (median [Q1-Q3]) vs 1.7% [0.80-2.55] (p < 0.001) and 1.9% [1.2-2.80] vs. 1.0% [0.55-2.3] (p < 0.01). There were no differences in mean APT-SI in the tumor core between low and high-grade tumors: 2.5% [1.80-4.0] vs. 3.25% [2.5-4.0]. The mean APT-SI was significantly higher in high-grade glioma compared to low-grade glioma: 3.4% [2.7-4] vs. 2.1% [1.7-2.5] (p < 0.001). Highest mean APT-SI in tumor core were found in mesenchymal tumors (5.83% ± 1.45, mean ± SD), embryonal tumors (5.27% ± 3.5) and meningiomas (4.28% ± 0.70). In tumor mimics, highest mean APT-SI was found in the core of infectious lesions (3.52% ± 0.67).

conclusionHigh signal on ATPwi is not exclusive to high-grade brain tumors but can be observed in some tumor mimics and subtypes of low-grade tumors. KEY POINTS: Question What is the value of amide proton transfer-weighted imaging (APTwi) in the setting of brain mass classification? Findings High APT-signal intensity in the tumor core of a brain mass could correspond to a high- or low-grade tumor or tumor mimic. Clinical relevance In patients presenting for the initial classification of brain masses, APTwi findings should be interpreted with caution and in conjunction with other MRI parameters, as a high APTwi signal does not necessarily indicate a high-grade tumor.

Indexed as

Brain NeoplasmsMagnetic Resonance ImagingAdultAgedAmidesDiagnosis, DifferentialFemaleHumansMaleMiddle AgedProtonsRetrospective StudiesAmidesProtonsAmide proton transfer-weighted imagingBrain tumorsMagnetic resonance imagingTumor mimics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.